CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Purdue Pharma LP v. Apotex Inc.

1:07-cv-00549

Overview

Case Number 1:07-cv-00549
Filing Date 2007-09-12
Status Terminated
Termination Date 2007-11-19
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal question
Cause of Action 35:271 Patent Infringement

Parties

Defendant

Apotex Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Purdue Pharma LP NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 6 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (6 found):
U.S. Courts: 6
U.S. District Court 2011-02-03
1:11-cv-00766

Purdue Pharma L.P. v. Varam, Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2007-06-06
1:07-cv-04810

Purdue Pharma L.P. v. KV Pharmaceutical Company

Asserted Patent
Status: NYSD
U.S. District Court 2007-01-16
1:07-cv-00032

Purdue Pharma LP v. KV Pharmaceuticals Company

Asserted Patent
Status: DED
U.S. District Court 2006-11-09
1:06-cv-13095

Purdue Pharma L.P. v. Mallinckrodt Inc.

Asserted Patent
Status: NYSD
U.S. District Court 2001-08-30
1:01-cv-08177

Purdue Pharma L.P. v. Endo Pharmaceuticals

Asserted Patent
Status: NYSD
U.S. District Court 2001-03-13
1:01-cv-02109

Purdue Pharma L.P. v. Endo Pharmaceuticals

Asserted Patent
Status: NYSD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US5508042
Controlled release oxycodone compositions
Filed: 1995-06-06
Issued: 1996-04-16
Expired (Term Ended)
Expires: 2015-06-06

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

2

Dispositive

0

Granted

0

Denied

0

Pending / Review

2

Motions by Category

Procedural / Extension Motion 2

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to November 15, 2007 - filed by Apotex Inc., Apotex Corp.. (Dorsney, Kenneth) (...
Entry #8 • 2007-11-01 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to November 2, 2007 - filed by Apotex Inc., Apotex Corp.. (Horwitz, Richard) (E...
Entry #7 • 2007-09-25 Document →

Docket Entries

(10 total)
Pleading / Complaint

COMPLAINT filed with Jury Demand against Apotex Inc., Apotex Corp. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 148873.) - filed by Purdue Pharma LP, PF Laboratories Inc., Purdue Pharmaceuticals LP. (Attachments: # 1 Exhibit A# 2 Civil Cover Sheet # 3 Acknowledgement of Consent Form)(ead) (Entered: 09/13/2007)

Entry #1 • 2007-09-12
1

Notice of Availability of a U.S. Magistrate Judge to Exercise Jurisdiction (ead) (Entered: 09/13/2007)

Entry #2 • 2007-09-12
1

Disclosure Statement pursuant to Rule 7.1 filed by Purdue Pharma LP, PF Laboratories Inc., Purdue Pharmaceuticals LP identifying Pharmaceuticals Research Associates Inc. as Corporate Parent to PF Laboratories Inc. (ead) (Entered: 09/14/2007)

Entry #5 • 2007-09-12
1

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,508,042; (ead) (Entered: 09/13/2007)

Entry #3 • 2007-09-13
1
Pleading / Complaint

Return of Service Executed by Purdue Pharma LP, PF Laboratories Inc., Purdue Pharmaceuticals LP. Apotex Corp. served on 9/12/2007, answer due 10/2/2007. (Smith, Rodger) (Entered: 09/13/2007)

Entry #4 • 2007-09-13
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc